Joaquim Mullol

48PUBLICATIONS
444CO-AUTHORS
AllergyCheminformatics and quantitative structure-activity relationshipsEcosystem services (incl. pollination)Noise and wave pollution processes and measurementOtorhinolaryngology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Apr 25, 2026
Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

|Apr 21, 2026
Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.

|Feb 02, 2026
The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position Paper.

L Klimek, J Mullol, Th Hummel

|Jan 06, 2026
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).

Joaquim Mullol, Joseph K Han, Tanya M Laidlaw

|Sep 01, 2025
Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR).

Carlo Cavaliere, Sven F Seys, Joost de Kinderen

|Apr 08, 2025
Benralizumab and the integrated management of co-morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps.

Joaquim Mullol, Maria D'Amato, Eugenio de Corso

Pageof 8

Frequent Collaborators

9 joint publications

Ioana Agache

9 joint publications

Wytske J Fokkens

9 joint publications

Oliver Pfaar

8 joint publications

Jean Bousquet